The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.
- Date and time Wed 1 Sep 2021 from 9:00am to 5:40pm
- Location Live stream - online
- Organised by Surgery, Coloproctology
To book to attend the event in London, click here.
At this meeting, a multidisciplinary faculty of top experts will provide state of the art lectures on current and emerging treatments for early rectal cancer.
You will learn about less aggressive treatments and stoma avoidance, with a focus on papillon radiotherapy, get updates on clinical trials, hear a patient perspective as part of the main programme, and will be able to discuss individual cases with national and international experts.
This event will educate, inform and influence professionals caring for patients with rectal cancer on the newer options available for the treatment of early tumours, taking into account patient perspectives and the provision of specialist services in the UK and abroad. Author Mark Davis will share his experience as a patient and a multidisciplinary audience will be part of panel discussions on the topics.
- To inform the audience about the current status of "Watch and Wait" strategy after (chemo) radiotherapy for early rectal cancer - both in the UK and world wide.
- To educate multidisciplinary team members including (but not exclusively) surgeons, oncologists, cancer nurses, pathologists and radiologists about the possibility of rectal preservation and stoma avoidance when treating early rectal cancer.
- To gain the patient perspective on this difficult area of decision making in cancer practice.
- To understand the influence of the Bowel Screening services on downward stage migration leading to increased diagnosis of earlier rectal cancer, and hence the need for less aggressive treatments.
We would like to thank our sponsors Ariane Medical Systems, Clatterbridge Cancer Centre, Clatterbridge Private Clinic, David Andrew Research Trust 43 (DART 43), SurgEase Innovations and Synmed for their support of this meeting. Please note that the scientific programme and content has not been influenced in any way by the sponsors.
Join in the conversation online
Follow us on Twitter: @RoySocMed
View the programme
Disclaimer: All views expressed in this live stream are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
This live stream will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place.
This live stream will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.